Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity.
Saved in:
| Title: | Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity. |
|---|---|
| Authors: | Pincus SH; Department of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59715, USA., Craig RB; Research Institute for Children, Children's Hospital, New Orleans, LA 70118, USA.; Department of Pathology, Tulane University, New Orleans, LA 70112, USA., Weachter L; Research Institute for Children, Children's Hospital, New Orleans, LA 70118, USA., LaBranche CC; Department of Surgery, Duke University, Durham, NC 27707, USA., Nabi R; Department of Microbiology, Immunology, and Parasitology, LSU School of Medicine, New Orleans, LA 70112, USA., Watt C; Department of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59715, USA., Raymond M; Department of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59715, USA., Peters T; Department of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59715, USA., Song K; Research Institute for Children, Children's Hospital, New Orleans, LA 70118, USA., Maresh GA; Research Institute for Children, Children's Hospital, New Orleans, LA 70118, USA., Montefiori DC; Department of Surgery, Duke University, Durham, NC 27707, USA., Kozlowski PA; Department of Microbiology, Immunology, and Parasitology, LSU School of Medicine, New Orleans, LA 70112, USA. |
| Source: | Vaccines [Vaccines (Basel)] 2021 Jul 12; Vol. 9 (7). Date of Electronic Publication: 2021 Jul 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2076-393X |
|---|---|
| DOI: | 10.3390/vaccines9070774 |
